Palivizumab 12714-0230
Product NDC
12714-0230- Manufacturer
- Boehringer Ingelheim Pharma Gmbh And Co. Kg
- Dosage Form
- Solution
- Product Type
- Bulk Ingredient
- Marketing Start
- September 4, 1998
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Palivizumab | 100 mg/100mg |
Packaging Options(1)
100 mg in 1 TANK (12714-230-10)